You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Immunol., 21 February 2024

Sec. Vaccines and Molecular Therapeutics

Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1377041

Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence

  • 1. Department of Immunology, Oslo University Hospital, Oslo, Norway

  • 2. KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

  • 3. NEC OncoImmunity AS, Oslo, Norway

  • 4. Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway

Article metrics

View details

1,2k

Views

516

Downloads

Text correction

In the published article, there were two errors: The “Material and methods” section preceded the “Introduction” section, and there was an inaccuracy in the wording of a sentence in the “Reagents” sub-section of “Material and methods”.

The “Introduction” now precedes the “Material and methods”, and a correction has been made to a sentence in “Materials and methods”, sub-section “Reagents”.

This sentence previously stated:

“Peptides were synthesized by GenScript (Piscataway, NJ, USA) at a purity ≥85%, and used at a final concentration of 1.5mg/mL each.”

The corrected sentence appears below:

“Peptides were synthesized by GenScript (Piscataway, NJ, USA) at a purity ≥85% and stored at a final concentration of 1.5mg/mL.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

T cell, COVID-19, CD8+ lymphocytes, CD4+ lymphocytes, vaccine, SARS-CoV-2, artificial intelligence, antigen (Ag)

Citation

Federico L, Malone B, Tennøe S, Chaban V, Osen JR, Gainullin M, Smorodina E, Kared H, Akbar R, Greiff V, Stratford R, Clancy T and Munthe LA (2024) Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence. Front. Immunol. 15:1377041. doi: 10.3389/fimmu.2024.1377041

Received

26 January 2024

Accepted

05 February 2024

Published

21 February 2024

Volume

15 - 2024

Edited and reviewed by

Elke Bergmann-Leitner, Walter Reed Army Institute of Research, United States

Updates

Copyright

*Correspondence: Lorenzo Federico, ; Ludvig Andre Munthe,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics